A real world comparison of sulfonylurea and insulin vs. incretin-based treatments in patients not controlled on prior metformin monotherapy
Crossref DOI link: https://doi.org/10.1186/s12933-015-0172-9
Published Print: 2015
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gitt, Anselm K
Bramlage, Peter
Schneider, Steffen
Tschöpe, Diethelm
License valid from 2015-01-01